MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients

SIMPLE SUMMARY: Experimental and clinical studies have revealed that vascular endothelial growth factor (VEGF) is the predominant angiogenic factor in breast cancer. VEGF expression correlates with inferior outcomes and advanced-stage breast cancer. Bevacizumab is a humanized anti-VEGF monoclonal an...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Torgeir, Brandal, Siri Helene Bertelsen, Geier, Oliver Marcel, Engebråten, Olav, Nilsen, Line Brennhaug, Kristensen, Vessela N., Hole, Knut Håkon, Hompland, Tord, Fleischer, Thomas, Seierstad, Therese
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526130/
https://www.ncbi.nlm.nih.gov/pubmed/37760629
http://dx.doi.org/10.3390/cancers15184662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526130/
https://www.ncbi.nlm.nih.gov/pubmed/37760629
http://dx.doi.org/10.3390/cancers15184662

Ejemplares similares